Lead In Silico Business Partner, Platform

Job Title: Lead In Silico Business Partner, Platform Job Type: Permanent Location: Abingdon - UK, Alderley Park- UK or Verona, Italy Our Company Evotec is a leader in the discovery and development of novel small molecule drugs with operational sites in Europe and the US. The Company has built substantial drug discovery expertise and an industrialised platform that can drive new innovative small molecule compounds into the clinic. In addition, Evotec has built a deep internal knowledge base in the treatment of diseases related to neuroscience, pain, oncology, inflammation and metabolic diseases. Leveraging these skills and expertise the Company intends to develop best-in-class differentiated therapeutics and deliver superior science-driven discovery alliances with pharmaceutical and biotechnology companies Purpose of the role The Lead In Silico Business Partner, Platform is the single front door between Evotec's Drug Discovery Platforms (DDP) segment and the global In Silico & AI organization, owning the relationship, the demand and the in silico roadmap for the segment worldwide. The role translates platform science priorities across DMPK, ADME/Tox, predictive and in vitro safety, hit identification and screening, biophysical and structural methods, bioanalysis, sample and reagent management and omics data generation into prioritized in silico and AI requirements, then orchestrates delivery across the capability units and holds it to quality, timing and measurable value. This is one of four Lead Business Partner seats in the newly established Strategy & Portfolio unit. It carries a commercial mandate alongside the scientific one: ADMET/Safety is one of three capabilities Evotec is industrializing as a differentiator, and this is the role that makes it land in the platform business. Core accountabilities Own the end to end relationship between the Drug Discovery Platforms segment and the In Silico & AI function globally, acting as the single accountable front door for all incoming demand so that work is scoped and staffed once, not duplicated across teams. Shape and own the in silico and AI roadmap for the platform business, with particular focus on ADMET/Safety and in vitro predictive safety (NAMs) as well as omics data generation, one of the three capabilities Evotec is industrializing as a differentiator. Capture, structure and prioritize demand from platform leadership, translating scientific and operational needs into clear, testable requirements together with Solution Managers, the AI Accelerator and Solutions & Data. Orchestrate the in silico contribution across Bioinformatics, Computational Biology, Therapeutics Design, AI Accelerator and Solutions & Data, ensuring alignment, delivery quality and timely execution. Partner with the omics data generation platforms to turn generated data into governed, reusable data assets that compound across projects, in close collaboration with IT&Data. Drive adoption at scale, moving in silico and AI capability out of pilot and into routine platform operation in place of repeated proofs of concept. Provide structured input to segment and portfolio level prioritization, including demand visibility, cross unit dependencies, resourcing needs, investment cases and expected value. Contribute the in silico content to client proposals and bids where platform services are in scope, working with Commercial, Business Development and Global Portfolio Management on differentiation and pricing. Track and evidence the value delivered, including margin uplift on in silico influenced work, cycle time and de-risking impact, and in silico attributed revenue, feeding this back into prioritization. Serve as moderator and escalation point for conflicting priorities, with support from the In Silico function heads. Represent In Silico & AI in platform leadership forums and act as a change agent for new ways of working across a global, multi site organization. Capability, Knowledge and Experience: Proven ability to build trusted relationships with senior scientific and operational leadership, and to influence without direct authority in a global matrix Working technical fluency in the in silico toolbox that platform science depends on: machine learning and QSAR based property and ADMET prediction, cheminformatics, structure based and biophysical methods, PBPK and PK/PD modelling, and multi omics analysis. Depth in several, credible literacy across all Practical understanding of the AI delivery lifecycle, including data quality and FAIR principles, model validation, MLOps, and what it takes to move a model from prototype into validated production use Real fluency in platform science, gained in one or more of DMPK, ADME/Tox, predictive and in vitro safety including NAMs, hit identification and screening, bioanalysis, or omics data generation Track record of translating between wet lab science and computational delivery, so that both sides recognise their own problem in the agreed requirement Commercial acumen: shaping proposals, building value and investment cases, and supporting pricing and differentiation conversations Strong portfolio, demand and project management discipline in complex, multi stakeholder environments Structured, proactive working style with the leadership presence to hold a line on prioritization Change leadership, with experience driving adoption of new technology or new ways of working across established teams Education and Qualifications: PhD or . in life sciences, chemistry, computational or data science, engineering, or a related discipline Previous experience in biotech, pharma, CRO, or a comparable science driven environment Demonstrable experience partnering with, or working inside, drug discovery platform functions such as DMPK, ADME/Tox, safety, screening, or omics Evidence of in silico or AI solutions delivered into routine scientific use, not only into pilot Experience working across multiple countries and sites in an international matrix organization Fluent business English; an additional European language is an advantage Willingness to travel occasionally between Evotec sites and to partner meetings FR : Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap. EN: In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities. IT: In compliance with fundamental ethical and professional principles and with Legislative Decree 198/2006, Evotec is an Equal Opportunity Employer committed to fostering a safe, diverse, and inclusive workplace built on mutual respect. We provide equal employment opportunities to all qualified candidates and employees based on their skills, experience, and professional qualifications. In line with our ethical and professional principles, all employment-related decisions, including recruitment and selection processes, are made fairly and without any form of discrimination. All qualified candidates will be considered for employment regardless of race, color, sex, age, disability, genetic information, gender expression, gender identity, nationality, religion, sexual orientation, or any other characteristic protected under applicable law.